Search Results | Litt's Drug Eruption and Reaction Database

Skip to main content

Nothing else can remotely compare to it.Patricia Wong, MD, Stanford University Medical Centre

Log in

Menu

Login

Home
About About
Alerts
Litt’s App
Contact Us
Help
Subscribe Subscribe
- Individual Subscription
- Institutional Subscription

Drugs belonging to

class – Renin-angiotensin-aldosterone system (RAAS) inhibitor – 25 items found

Search:

show all
0–9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Azilsartan Compare:

Benazepril Compare:

Candesartan Compare:

Captopril Compare:

Cilazapril Compare:

Enalapril Compare:

Eplerenone Compare:

Eprosartan Compare:

Finerenone Compare:

Fosinopril Compare:

Imidapril Compare:

Irbesartan Compare:

Lisinopril Compare:

Losartan Compare:

Moexipril Compare:

Olmesartan Compare:

Perindopril Compare:

Quinapril Compare:

Ramipril Compare:

Sacubitril/Valsartan Compare:

Loading more results

No more results to show

Adverse reactions attributed to entire drug class 'Renin-angiotensin-aldosterone system (RAAS) inhibitor'

Use of inhibitors of the renin-angiotensin-aldosterone system (RAAS) is contraindicated in the second and third trimesters of pregnancy.

Please login to view adverse reactions.

Adverse pregnancy outcomes

(2025): Greenlees C+, J Hum Hypertens 39(5), 315-319 [Review]

Fetotoxicity / fetopathy

(2026): Komatsu H+, CEN Case Rep 15(6), 159 (1 case)
(2020): Weber-Schoendorfer C+, J Hypertens 38(1), 133-141 (59 pregnancies)
(2015): Nadeem S+, J Pediatr 167(4), 881-5 (24 cases)
(2012): Bullo M+, Hypertension 60(2), 444-50 [Review]
(2006): Quan A, Early Hum Dev 82(1), 23-8

Use of inhibitors of the renin-angiotensin-aldosterone system (RAAS) is contraindicated in the second and third trimesters of pregnancy.

Saved Searches Watched Drugs

Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone! If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Help
Terms & Conditions
Privacy
Disclaimer
Contact us

© 2026 Taylor & Francis Group, LLC. All Rights Reserved.